{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:21:12Z","timestamp":1788268872235,"version":"build-2803163510"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increasing cGMP is a unique therapeutic principle, and drugs inhibiting cGMP-degrading enzymes or stimulating cGMP production are approved for the treatment of various diseases such as erectile dysfunction, coronary artery disease, pulmonary hypertension, chronic heart failure, irritable bowel syndrome, or achondroplasia. In addition, cGMP-increasing therapies are preclinically profiled or in clinical development for quite a broad set of additional indications, e.g., neurodegenerative diseases or different forms of dementias, bone formation disorders, underlining the pivotal role of cGMP signaling pathways. The fundamental understanding of the signaling mediated by nitric oxide-sensitive (soluble) guanylyl cyclase and membrane-associated receptor (particulate) guanylyl cyclase at the molecular and cellular levels, as well as in vivo, especially in disease models, is a key prerequisite to fully exploit treatment opportunities and potential risks that could be associated with an excessive increase in cGMP. Furthermore, human genetic data and the clinical effects of cGMP-increasing drugs allow back-translation into basic research to further learn about signaling and treatment opportunities. The biannual international cGMP conference, launched nearly 20\u00a0years ago, brings all these aspects together as an established and important forum for all topics from basic science to clinical research and pivotal clinical trials. This review summarizes the contributions to the \u201c10th cGMP Conference on cGMP Generators, Effectors and Therapeutic Implications,\u201d which was held in Augsburg in 2022 but will also provide an overview of recent key achievements and activities in the field of cGMP research.<\/jats:p>","DOI":"10.1007\/s00210-023-02484-8","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:28:14Z","timestamp":1682000894000},"page":"1669-1686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The 10th International Conference on cGMP 2022: recent trends in cGMP research and development\u2014meeting report"],"prefix":"10.1007","volume":"396","author":[{"given":"Andreas","family":"Friebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan R.","family":"Kraehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Russwurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Schmidtko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"2484_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jchf.2017.08.013","volume":"6","author":"PW Armstrong","year":"2018","unstructured":"Armstrong PW, Roessig L, Patel MJ, Anstrom KJ, Butler J, Voors AA, Lam CSP, Ponikowski P, Temple T, Pieske B, Ezekowitz J, Hernandez AF, Koglin J, O\u2019Connor CM (2018) A multicenter, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral soluble guanylate cyclase stimulator: the VICTORIA trial. JACC Heart Fail 6:96\u2013104","journal-title":"JACC Heart Fail"},{"key":"2484_CR2","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1001\/jama.2020.15922","volume":"324","author":"PW Armstrong","year":"2020","unstructured":"Armstrong PW, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O\u2019Connor CM, Pieske B, Ponikowski P, Shah SJ, Solomon SD, Voors AA, She L, Vlajnic V, Carvalho F, Bamber L, Blaustein RO, Roessig L, Butler J, Group VI-HS (2020) Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction: the VITALITY-HFpEF randomized clinical trial. JAMA 324:1512\u20131521","journal-title":"JAMA"},{"key":"2484_CR3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/CIRCULATIONAHA.120.052414","volume":"143","author":"MI Aslam","year":"2021","unstructured":"Aslam MI, Hahn VS, Jani V, Hsu S, Sharma K, Kass DA (2021) Reduced right ventricular sarcomere contractility in heart failure with preserved ejection fraction and severe obesity. Circulation 143:965\u2013967","journal-title":"Circulation"},{"key":"2484_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.tins.2022.07.001","volume":"45","author":"DCA Barret","year":"2022","unstructured":"Barret DCA, Kaupp UB, Marino J (2022) The structure of cyclic nucleotide-gated channels in rod and cone photoreceptors. Trends Neurosci 45:763\u2013776","journal-title":"Trends Neurosci"},{"key":"2484_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12931-022-02189-1","volume":"23","author":"EM Becker-Pelster","year":"2022","unstructured":"Becker-Pelster EM, Hahn MG, Delbeck M, Dietz L, Huser J, Kopf J, Kraemer T, Marquardt T, Mondritzki T, Nagelschmitz J, Nikkho SM, Pires PV, Tinel H, Weimann G, Wunder F, Sandner P, Schuhmacher J, Stasch JP, Truebel HKF (2022) Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC. Respir Res 23:272","journal-title":"Respir Res"},{"key":"2484_CR6","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s00210-021-02149-4","volume":"394","author":"A Benardeau","year":"2021","unstructured":"Benardeau A, Kahnert A, Schomber T, Meyer J, Pavkovic M, Kretschmer A, Lawrenz B, Hartmann E, Mathar I, Hueser J, Kraehling JR, Eitner F, Hahn MG, Stasch JP, Sandner P (2021) Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease. Naunyn Schmiedebergs Arch Pharmacol 394:2363\u20132379","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2484_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jprot.2016.02.009","volume":"138","author":"A Beuve","year":"2016","unstructured":"Beuve A, Wu C, Cui C, Liu T, Jain MR, Huang C, Yan L, Kholodovych V, Li H (2016) Identification of novel S-nitrosation sites in soluble guanylyl cyclase, the nitric oxide receptor. J Proteomics 138:40\u201347","journal-title":"J Proteomics"},{"key":"2484_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102179","volume":"48","author":"NI Bork","year":"2021","unstructured":"Bork NI, Kuret A, Cruz Santos M, Molina CE, Reiter B, Reichenspurner H, Friebe A, Skryabin BV, Rozhdestvensky TS, Kuhn M, Lukowski R, Nikolaev VO (2021) Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia. Redox Biol 48:102179","journal-title":"Redox Biol"},{"key":"2484_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.005998","volume":"12","author":"J Butler","year":"2019","unstructured":"Butler J, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O\u2019Connor CM, Pieske B, Ponikowski P, Shah SJ, Solomon SD, Voors AA, Wu Y, Carvalho F, Bamber L, Blaustein RO, Roessig L, Armstrong PW (2019) Rationale and design of the VITALITY-HFpEF trial. Circ Heart Fail 12:e005998","journal-title":"Circ Heart Fail"},{"key":"2484_CR10","doi-asserted-by":"publisher","unstructured":"Calamaras TD, Pande S, Baumgartner RA, Kim SK, McCarthy JC, Martin GL, Tam K, McLaughlin AL, Wang GR, Aronovitz MJ, Lin W, Aguirre JI, Baca P, Liu P, Richards DA, Davis RJ, Karas RH, Jaffe IZ, Blanton RM (2021) MLK3 mediates impact of PKG1alpha on cardiac function and controls blood pressure through separate mechanisms.\u00a0JCI Insight 6(18):e149075. https:\/\/doi.org\/10.1172\/jci.insight.149075","DOI":"10.1172\/jci.insight.149075"},{"key":"2484_CR11","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.2337\/db21-0100","volume":"70","author":"RP Ceddia","year":"2021","unstructured":"Ceddia RP, Liu D, Shi F, Crowder MK, Mishra S, Kass DA, Collins S (2021) Increased energy expenditure and protection from diet-induced obesity in mice lacking the cgmp-specific phosphodiesterase PDE9. Diabetes 70:2823\u20132836","journal-title":"Diabetes"},{"key":"2484_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.656561","volume":"12","author":"SS Correia","year":"2021","unstructured":"Correia SS, Iyengar RR, Germano P, Tang K, Bernier SG, Schwartzkopf CD, Tobin J, Lee TW, Liu G, Jacobson S, Carvalho A, Rennie GR, Jung J, Renhowe PA, Lonie E, Winrow CJ, Hadcock JR, Jones JE, Currie MG (2021a) The CNS-penetrant soluble guanylate cyclase stimulator CY6463 reveals its therapeutic potential in neurodegenerative diseases. Front Pharmacol 12:656561","journal-title":"Front Pharmacol"},{"key":"2484_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12974-021-02275-z","volume":"18","author":"SS Correia","year":"2021","unstructured":"Correia SS, Liu G, Jacobson S, Bernier SG, Tobin JV, Schwartzkopf CD, Atwater E, Lonie E, Rivers S, Carvalho A, Germano P, Tang K, Iyengar RR, Currie MG, Hadcock JR, Winrow CJ, Jones JE (2021b) The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system. J Neuroinflammation 18:213","journal-title":"J Neuroinflammation"},{"key":"2484_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102425","volume":"55","author":"C Cui","year":"2022","unstructured":"Cui C, Wu C, Shu P, Liu T, Li H, Beuve A (2022) Soluble guanylyl cyclase mediates noncanonical nitric oxide signaling by nitrosothiol transfer under oxidative stress. Redox Biol 55:102425","journal-title":"Redox Biol"},{"key":"2484_CR15","doi-asserted-by":"publisher","unstructured":"Dai Y, Faul EM, Ghosh A, Stuehr DJ (2022) NO rapidly mobilizes cellular heme to trigger assembly of its own receptor.\u00a0Proc Natl Acad\u00a0Sci U S A 119(4):e2115774119. https:\/\/doi.org\/10.1073\/pnas.2115774119","DOI":"10.1073\/pnas.2115774119"},{"key":"2484_CR16","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1038\/s41467-021-22933-3","volume":"12","author":"A de la Fuente-Alonso","year":"2021","unstructured":"de la Fuente-Alonso A, Toral M, Alfayate A, Ruiz-Rodriguez MJ, Bonzon-Kulichenko E, Teixido-Tura G, Martinez-Martinez S, Mendez-Olivares MJ, Lopez-Maderuelo D, Gonzalez-Valdes I, Garcia-Izquierdo E, Mingo S, Martin CE, Muino-Mosquera L, De Backer J, Nistal JF, Forteza A, Evangelista A, Vazquez J, Campanero MR, Redondo JM (2021) Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO. Nat Commun 12:2628","journal-title":"Nat Commun"},{"key":"2484_CR17","doi-asserted-by":"publisher","first-page":"1007026","DOI":"10.3389\/fnmol.2022.1007026","volume":"15","author":"JR Egbert","year":"2022","unstructured":"Egbert JR, Uliasz TF, Lowther KM, Kaback D, Wagner BM, Healy CL, O\u2019Connell TD, Potter LR, Jaffe LA, Yee SP (2022) Epitope-tagged and phosphomimetic mouse models for investigating natriuretic peptide-stimulated receptor guanylyl cyclases. Front Mol Neurosci 15:1007026","journal-title":"Front Mol Neurosci"},{"key":"2484_CR18","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.jacc.2020.08.031","volume":"76","author":"M Emdin","year":"2020","unstructured":"Emdin M, Aimo A, Castiglione V, Vergaro G, Georgiopoulos G, Saccaro LF, Lombardi CM, Passino C, Cerbai E, Metra M, Senni M (2020) Targeting cyclic guanosine monophosphate to treat heart failure: JACC Review Topic of the Week. J Am Coll Cardiol 76:1795\u20131807","journal-title":"J Am Coll Cardiol"},{"key":"2484_CR19","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1021\/acs.jmedchem.7b00449","volume":"60","author":"M Follmann","year":"2017","unstructured":"Follmann M, Ackerstaff J, Redlich G, Wunder F, Lang D, Kern A, Fey P, Griebenow N, Kroh W, Becker-Pelster EM, Kretschmer A, Geiss V, Li V, Straub A, Mittendorf J, Jautelat R, Schirok H, Schlemmer KH, Lustig K, Gerisch M, Knorr A, Tinel H, Mondritzki T, Trubel H, Sandner P, Stasch JP (2017) Discovery of the soluble guanylate cyclase stimulator vericiguat (BAY 1021189) for the treatment of chronic heart failure. J Med Chem 60:5146\u20135161","journal-title":"J Med Chem"},{"key":"2484_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/cvr\/cvy039","volume":"114","author":"S Frankenreiter","year":"2018","unstructured":"Frankenreiter S, Groneberg D, Kuret A, Krieg T, Ruth P, Friebe A, Lukowski R (2018) Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase. Cardiovasc Res 114:822\u2013829","journal-title":"Cardiovasc Res"},{"key":"2484_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.niox.2018.03.020","volume":"77","author":"A Friebe","year":"2018","unstructured":"Friebe A, Voussen B, Groneberg D (2018) NO-GC in cells \u201coff the beaten track.\u201d Nitric Oxide Biol Chem 77:12\u201318","journal-title":"Nitric Oxide Biol Chem"},{"key":"2484_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/bph.14532","volume":"176","author":"J Garthwaite","year":"2019","unstructured":"Garthwaite J (2019) NO as a multimodal transmitter in the brain: discovery and current status. Br J Pharmacol 176:197\u2013211","journal-title":"Br J Pharmacol"},{"key":"2484_CR23","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.2015.15734","volume":"314","author":"M Gheorghiade","year":"2015","unstructured":"Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP, Ponikowski P, Shah SJ, Solomon SD, Kraigher-Krainer E, Samano ET, Muller K, Roessig L, Pieske B, Investigators S-R, Coordinators, (2015) Effect of Vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial. JAMA 314:2251\u20132262","journal-title":"JAMA"},{"key":"2484_CR24","doi-asserted-by":"publisher","first-page":"15259","DOI":"10.1074\/jbc.M114.559393","volume":"289","author":"A Ghosh","year":"2014","unstructured":"Ghosh A, Stasch JP, Papapetropoulos A, Stuehr DJ (2014) Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content. J Biol Chem 289:15259\u201315271","journal-title":"J Biol Chem"},{"key":"2484_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ejn.15564","volume":"55","author":"J Giesen","year":"2022","unstructured":"Giesen J, Mergia E, Koesling D, Russwurm M (2022) Hippocampal AMPA- and NMDA-induced cGMP signals are mainly generated by NO-GC2 and are under tight control by PDEs 1 and 2. Eur J Neurosci 55:18\u201331","journal-title":"Eur J Neurosci"},{"key":"2484_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/CIRCRESAHA.114.302437","volume":"114","author":"KR Goetz","year":"2014","unstructured":"Goetz KR, Sprenger JU, Perera RK, Steinbrecher JH, Lehnart SE, Kuhn M, Gorelik J, Balligand JL, Nikolaev VO (2014) Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes. Circ Res 114:1235\u20131245","journal-title":"Circ Res"},{"key":"2484_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00424-020-02347-8","volume":"472","author":"N Habek","year":"2020","unstructured":"Habek N, Dobrivojevic Radmilovic M, Kordic M, Ilic K, Grgic S, Farkas V, Bagaric R, Skokic S, Svarc A, Dugandzic A (2020) Activation of brown adipose tissue in diet-induced thermogenesis is GC-C dependent. Pflugers Arch 472:405\u2013417","journal-title":"Pflugers Arch"},{"key":"2484_CR28","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1021\/acs.jmedchem.0c02154","volume":"64","author":"MG Hahn","year":"2021","unstructured":"Hahn MG, Lampe T, El Sheikh S, Griebenow N, Woltering E, Schlemmer KH, Dietz L, Gerisch M, Wunder F, Becker-Pelster EM, Mondritzki T, Tinel H, Knorr A, Kern A, Lang D, Hueser J, Schomber T, Benardeau A, Eitner F, Truebel H, Mittendorf J, Kumar V, van den Akker F, Schaefer M, Geiss V, Sandner P, Stasch JP (2021) Discovery of the soluble guanylate cyclase activator runcaciguat (BAY 1101042). J Med Chem 64:5323\u20135344","journal-title":"J Med Chem"},{"key":"2484_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bcp.2016.10.008","volume":"122","author":"J Hochheiser","year":"2016","unstructured":"Hochheiser J, Haase T, Busker M, Sommer A, Kreienkamp HJ, Behrends S (2016) Heterodimerization with the beta1 subunit directs the alpha2 subunit of nitric oxide-sensitive guanylyl cyclase to calcium-insensitive cell-cell contacts in HEK293 cells: Interaction with Lin7a. Biochem Pharmacol 122:23\u201332","journal-title":"Biochem Pharmacol"},{"key":"2484_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1515\/hsz-2019-0386","volume":"401","author":"F Hofmann","year":"2020","unstructured":"Hofmann F (2020) The cGMP system: components and function. Biol Chem 401:447\u2013469","journal-title":"Biol Chem"},{"key":"2484_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.17925\/HI.2022.16.2.112","volume":"16","author":"Y Horiuchi","year":"2022","unstructured":"Horiuchi Y, Villacorta H, Maisel AS (2022) Natriuretic peptide-guided therapy for heart failure. Heart Int 16:112\u2013116","journal-title":"Heart Int"},{"key":"2484_CR32","doi-asserted-by":"publisher","unstructured":"Horst BG, Yokom AL, Rosenberg DJ, Morris KL, Hammel M, Hurley JH, Marletta MA (2019) Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy.\u00a0eLife 8:e50634. https:\/\/doi.org\/10.7554\/eLife.50634","DOI":"10.7554\/eLife.50634"},{"key":"2484_CR33","doi-asserted-by":"publisher","unstructured":"Ichiki T, Jinno A, Tsuji Y (2022) Natriuretic peptide-based novel therapeutics: long journeys of drug developments optimized for disease states.\u00a0Biology (Basel) 11(6):859. https:\/\/doi.org\/10.3390\/biology11060859","DOI":"10.3390\/biology11060859"},{"key":"2484_CR34","doi-asserted-by":"publisher","unstructured":"Kalyanaraman H, Pal China S, Cabriales JA, Moininazeri J, Casteel DE, Garcia JJ, Wong VW, Chen A, Sah RL, Boss GR, Pilz RB (2022) Protein kinase G2 is essential for skeletal homeostasis and adaptation to mechanical loading in male but not female mice.\u00a0J Bone Miner Res 38(1):171\u2013185. https:\/\/doi.org\/10.1002\/jbmr.4746","DOI":"10.1002\/jbmr.4746"},{"key":"2484_CR35","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.122.18756","volume":"79","author":"A Kamynina","year":"2022","unstructured":"Kamynina A, Guttzeit S, Eaton P, Cuello F (2022) Nitroxyl Donor CXL-1020 Lowers blood pressure by targeting C195 in cyclic guanosine-3\u2019,5\u2019-monophosphate-dependent protein kinase I. Hypertension 79:946\u2013956","journal-title":"Hypertension"},{"key":"2484_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41586-019-1584-6","volume":"574","author":"Y Kang","year":"2019","unstructured":"Kang Y, Liu R, Wu JX, Chen L (2019) Structural insights into the mechanism of human soluble guanylate cyclase. Nature 574:206\u2013210","journal-title":"Nature"},{"key":"2484_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.14486","volume":"1487","author":"SM Kim","year":"2021","unstructured":"Kim SM, Yuen T, Iqbal J, Rubin MR, Zaidi M (2021) The NO-cGMP-PKG pathway in skeletal remodeling. Ann N Y Acad Sci 1487:21\u201330","journal-title":"Ann N Y Acad Sci"},{"key":"2484_CR38","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1152\/physrev.00022.2015","volume":"96","author":"M Kuhn","year":"2016","unstructured":"Kuhn M (2016) Molecular physiology of membrane guanylyl cyclase receptors. Physiol Rev 96:751\u2013804","journal-title":"Physiol Rev"},{"key":"2484_CR39","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/j.amjcard.2017.06.013","volume":"120","author":"K Leineweber","year":"2017","unstructured":"Leineweber K, Moosmang S, Paulson D (2017) Genetics of NO deficiency. Am J Cardiol 120:S80\u2013S88","journal-title":"Am J Cardiol"},{"key":"2484_CR40","doi-asserted-by":"publisher","unstructured":"Liu R, Kang Y, Chen L (2021) Activation mechanism of human soluble guanylate cyclase by stimulators and activators. Nat Commun 12(1):5492. https:\/\/doi.org\/10.1038\/s41467-021-25617-0","DOI":"10.1038\/s41467-021-25617-0"},{"key":"2484_CR41","doi-asserted-by":"publisher","first-page":"H513","DOI":"10.1152\/ajpheart.00660.2021","volume":"323","author":"PW Liu","year":"2022","unstructured":"Liu PW, Martin GL, Lin W, Huang W, Pande S, Aronovitz MJ, Davis RJ, Blanton RM (2022) Mixed lineage kinase 3 requires a functional CRIB domain for regulation of blood pressure, cardiac hypertrophy, and left ventricular function. Am J Physiol Heart Circ Physiol 323:H513\u2013H522","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2484_CR42","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1111\/bph.15824","volume":"179","author":"R Lukowski","year":"2022","unstructured":"Lukowski R, Feil R (2022) Recent developments in cGMP research: from mechanisms to medicines and back. Br J Pharmacol 179:2321\u20132327","journal-title":"Br J Pharmacol"},{"key":"2484_CR43","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1016\/j.cell.2022.06.010","volume":"185","author":"JO Lundberg","year":"2022","unstructured":"Lundberg JO, Weitzberg E (2022) Nitric oxide signaling in health and disease. Cell 185:2853\u20132878","journal-title":"Cell"},{"key":"2484_CR44","doi-asserted-by":"publisher","unstructured":"Ly OT, Chen H, Brown GE, Hong L, Wang X, Han YD, Pavel MA, Sridhar A, Maienschein-Cline M, Chalazan B, Ong SG, Abdelhady K, Massad M, Rizkallah LE, Rehman J, Khetani SR, Darbar D (2022) Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC-derived atrial fibrillation model.\u00a0JCI Insight 7(7):e155640. https:\/\/doi.org\/10.1172\/jci.insight.155640","DOI":"10.1172\/jci.insight.155640"},{"key":"2484_CR45","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/cvr\/cvab167","volume":"118","author":"O Manfra","year":"2022","unstructured":"Manfra O, Calamera G, Froese A, Arunthavarajah D, Surdo NC, Meier S, Melleby AO, Aasrum M, Aronsen JM, Nikolaev VO, Zaccolo M, Moltzau LR, Levy FO, Andressen KW (2022) CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors. Cardiovasc Res 118:1506\u20131519","journal-title":"Cardiovasc Res"},{"key":"2484_CR46","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40265-021-01496-z","volume":"81","author":"A Markham","year":"2021","unstructured":"Markham A, Duggan S (2021) Vericiguat: first approval. Drugs 81:721\u2013726","journal-title":"Drugs"},{"key":"2484_CR47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491","volume":"141","author":"JJV McMurray","year":"2020","unstructured":"McMurray JJV, Jackson AM, Lam CSP, Redfield MM, Anand IS, Ge J, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Rizkala AR, Sabarwal SV, Shah AM, Shah SJ, Shi VC, van Veldhuisen DJ, Zannad F, Zile MR, Cikes M, Goncalvesova E, Katova T, Kosztin A, Lelonek M, Sweitzer N, Vardeny O, Claggett B, Jhund PS, Solomon SD (2020) Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF. Circulation 141:338\u2013351","journal-title":"Circulation"},{"key":"2484_CR48","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1111\/bph.14835","volume":"176","author":"L Menges","year":"2019","unstructured":"Menges L, Krawutschke C, Fuchtbauer EM, Fuchtbauer A, Sandner P, Koesling D, Russwurm M (2019) Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts. Br J Pharmacol 176:4696\u20134707","journal-title":"Br J Pharmacol"},{"key":"2484_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0898-6568(02)00078-5","volume":"15","author":"E Mergia","year":"2003","unstructured":"Mergia E, Russwurm M, Zoidl G, Koesling D (2003) Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain. Cell Signal 15:189\u2013195","journal-title":"Cell Signal"},{"key":"2484_CR50","doi-asserted-by":"publisher","unstructured":"Michalakis S, Becirovic E, Biel M (2018) Retinal cyclic nucleotide-gated channels: from pathophysiology to therapy. Int J Mol Sci 19(3):749. https:\/\/doi.org\/10.3390\/ijms19030749","DOI":"10.3390\/ijms19030749"},{"key":"2484_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40291-021-00565-z","volume":"26","author":"S Michalakis","year":"2022","unstructured":"Michalakis S, Gerhardt M, Rudolph G, Priglinger S, Priglinger C (2022) Achromatopsia: genetics and gene therapy. Mol Diagn Ther 26:51\u201359","journal-title":"Mol Diagn Ther"},{"key":"2484_CR52","doi-asserted-by":"crossref","unstructured":"Mishra S, Sadagopan N, Dunkerly-Eyring B, Rodriguez S, Sarver DC, Ceddia RP, Murphy SA, Knutsdottir H, Jani VP, Ashok D, Oeing CU, O'Rourke B, Gangoiti JA, Sears DD, Wong GW, Collins S, Kass DA (2021) Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice. J Clin Investig 131(21):e148798","DOI":"10.1172\/JCI148798"},{"key":"2484_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/bs.acc.2022.09.005","volume":"112","author":"IK Mohan","year":"2023","unstructured":"Mohan IK, Baba K, Iyyapu R, Thirumalasetty S, Satish OS (2023) Advances in congestive heart failure biomarkers. Adv Clin Chem 112:205\u2013248","journal-title":"Adv Clin Chem"},{"key":"2484_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apha.2016.05.001","volume":"77","author":"FZ Monica","year":"2016","unstructured":"Monica FZ, Bian K, Murad F (2016) The endothelium-dependent nitric oxide-cGMP pathway. Adv Pharmacol 77:1\u201327","journal-title":"Adv Pharmacol"},{"key":"2484_CR55","doi-asserted-by":"publisher","unstructured":"Moyes AJ, Hobbs AJ (2019) C-type natriuretic peptide: a multifaceted paracrine regulator in the heart and vasculature.\u00a0Int J Mol Sci 20(9):2281. https:\/\/doi.org\/10.3390\/ijms20092281","DOI":"10.3390\/ijms20092281"},{"key":"2484_CR56","doi-asserted-by":"publisher","unstructured":"Nelissen E, Argyrousi EK, Van Goethem NP, Zhao F, Hines CDG, Swaminath G, Gerisch M, Hueser J, Sandner P, Prickaerts J (2021) Soluble guanylate cyclase stimulator vericiguat enhances long-term memory in rats without altering cerebral blood volume. Biomedicines\u00a09(8):1047. https:\/\/doi.org\/10.3390\/biomedicines9081047","DOI":"10.3390\/biomedicines9081047"},{"key":"2484_CR57","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1038\/s41598-022-07391-1","volume":"12","author":"E Nelissen","year":"2022","unstructured":"Nelissen E, Possemis N, Van Goethem NP, Schepers M, Mulder-Jongen DAJ, Dietz L, Janssen W, Gerisch M, Huser J, Sandner P, Vanmierlo T, Prickaerts J (2022) The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms. Sci Rep 12:3589","journal-title":"Sci Rep"},{"key":"2484_CR58","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nm.4266","volume":"23","author":"J Oller","year":"2017","unstructured":"Oller J, Mendez-Barbero N, Ruiz EJ, Villahoz S, Renard M, Canelas LI, Briones AM, Alberca R, Lozano-Vidal N, Hurle MA, Milewicz D, Evangelista A, Salaices M, Nistal JF, Jimenez-Borreguero LJ, De Backer J, Campanero MR, Redondo JM (2017) Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome. Nat Med 23:200\u2013212","journal-title":"Nat Med"},{"key":"2484_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315\u2013424","journal-title":"Physiol Rev"},{"key":"2484_CR60","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013392","volume":"13","author":"M Pavlou","year":"2021","unstructured":"Pavlou M, Schon C, Occelli LM, Rossi A, Meumann N, Boyd RF, Bartoe JT, Siedlecki J, Gerhardt MJ, Babutzka S, Bogedein J, Wagner JE, Priglinger SG, Biel M, Petersen-Jones SM, Buning H, Michalakis S (2021) Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders. EMBO Mol Med 13:e13392","journal-title":"EMBO Mol Med"},{"key":"2484_CR61","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/CIRCULATIONAHA.108.783753","volume":"118","author":"GD Pearson","year":"2008","unstructured":"Pearson GD, Devereux R, Loeys B, Maslen C, Milewicz D, Pyeritz R, Ramirez F, Rifkin D, Sakai L, Svensson L, Wessels A, Van Eyk J, Dietz HC, National Heart L, Blood I, Working NMF, G, (2008) Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation 118:785\u2013791","journal-title":"Circulation"},{"key":"2484_CR62","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/940207","volume":"2015","author":"CA Peixoto","year":"2015","unstructured":"Peixoto CA, Nunes AK, Garcia-Osta A (2015) Phosphodiesterase-5 inhibitors: action on the signaling pathways of neuroinflammation, neurodegeneration, and cognition. Mediators Inflamm 2015:940207","journal-title":"Mediators Inflamm"},{"key":"2484_CR63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116470119","volume":"119","author":"C Perez-Ternero","year":"2022","unstructured":"Perez-Ternero C, Aubdool AA, Makwana R, Sanger GJ, Stimson RH, Chan LF, Moyes AJ, Hobbs AJ (2022) C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis. Proc Natl Acad Sci USA 119:e2116470119","journal-title":"Proc Natl Acad Sci USA"},{"key":"2484_CR64","doi-asserted-by":"crossref","unstructured":"Peters S, Paolillo M, Mergia E, Koesling D, Kennel L, Schmidtko A, Russwurm M, Feil R (2018) cGMP imaging in brain slices reveals brain region-specific activity of NO-sensitive guanylyl cyclases (NO-GCs) and NO-GC stimulators. Int J Mol Sci\u00a019(8):2313","DOI":"10.3390\/ijms19082313"},{"key":"2484_CR65","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/j.pain.0000000000001440","volume":"160","author":"J Petersen","year":"2019","unstructured":"Petersen J, Mergia E, Kennel L, Drees O, Steubing RD, Real CI, Kallenborn-Gerhardt W, Lu R, Friebe A, Koesling D, Schmidtko A (2019) Distinct functions of soluble guanylyl cyclase isoforms NO-GC1 and NO-GC2 in inflammatory and neuropathic pain processing. Pain 160:607\u2013618","journal-title":"Pain"},{"key":"2484_CR66","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/cvr\/cvab240","volume":"118","author":"A Petraina","year":"2022","unstructured":"Petraina A, Nogales C, Krahn T, Mucke H, Luscher TF, Fischmeister R, Kass DA, Burnett JC, Hobbs AJ, Schmidt H (2022) Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology. Cardiovasc Res 118:2085\u20132102","journal-title":"Cardiovasc Res"},{"key":"2484_CR67","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/ejhf.135","volume":"16","author":"B Pieske","year":"2014","unstructured":"Pieske B, Butler J, Filippatos G, Lam C, Maggioni AP, Ponikowski P, Shah S, Solomon S, Kraigher-Krainer E, Samano ET, Scalise AV, Muller K, Roessig L, Gheorghiade M, Investigators S, Coordinators (2014) Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES). Eur J Heart Fail 16:1026\u20131038","journal-title":"Eur J Heart Fail"},{"key":"2484_CR68","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","volume":"38","author":"B Pieske","year":"2017","unstructured":"Pieske B, Maggioni AP, Lam CSP, Pieske-Kraigher E, Filippatos G, Butler J, Ponikowski P, Shah SJ, Solomon SD, Scalise AV, Mueller K, Roessig L, Gheorghiade M (2017) Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study. Eur Heart J 38:1119\u20131127","journal-title":"Eur Heart J"},{"key":"2484_CR69","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.cellsig.2011.09.001","volume":"23","author":"LR Potter","year":"2011","unstructured":"Potter LR (2011a) Guanylyl cyclase structure, function and regulation. Cell Signal 23:1921\u20131926","journal-title":"Cell Signal"},{"key":"2484_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pharmthera.2010.12.005","volume":"130","author":"LR Potter","year":"2011","unstructured":"Potter LR (2011b) Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases. Pharmacol Ther 130:71\u201382","journal-title":"Pharmacol Ther"},{"key":"2484_CR71","doi-asserted-by":"publisher","unstructured":"Reichel FF, Seitz I, Wozar F, Dimopoulos S, Jung R, Kempf M, Kohl S, Kortum FC, Ott S, Pohl L, Stingl K, Bartz-Schmidt KU, Stingl K, Fischer MD (2022) Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-321023","DOI":"10.1136\/bjophthalmol-2021-321023"},{"key":"2484_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/164_2018_117","volume":"251","author":"L Reverte-Salisa","year":"2019","unstructured":"Reverte-Salisa L, Sanyal A, Pfeifer A (2019) Role of cAMP and cGMP signaling in brown fat. Handb Exp Pharmacol 251:161\u2013182","journal-title":"Handb Exp Pharmacol"},{"issue":"4003\u20134012","key":"2484_CR73","volume":"27","author":"O Ros","year":"2019","unstructured":"Ros O, Zagar Y, Ribes S, Baudet S, Loulier K, Couvet S, Ladarre D, Aghaie A, Louail A, Petit C, Mechulam Y, Lenkei Z, Nicol X (2019) SponGee: a genetic tool for subcellular and cell-specific cGMP manipulation. Cell Rep 27(4003\u20134012):e4006","journal-title":"Cell Rep"},{"key":"2484_CR74","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1126\/science.1138956","volume":"317","author":"AF Rubin","year":"2007","unstructured":"Rubin AF, Green P (2007) Comment on \u201cThe consensus coding sequences of human breast and colorectal cancers.\u201d Science 317:1500","journal-title":"Science"},{"issue":"Pt 1","key":"2484_CR75","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1042\/bj3350125","volume":"335","author":"M Russwurm","year":"1998","unstructured":"Russwurm M, Behrends S, Harteneck C, Koesling D (1998) Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem J 335(Pt 1):125\u2013130","journal-title":"Biochem J"},{"key":"2484_CR76","doi-asserted-by":"publisher","first-page":"44647","DOI":"10.1074\/jbc.M105587200","volume":"276","author":"M Russwurm","year":"2001","unstructured":"Russwurm M, Wittau N, Koesling D (2001) Guanylyl cyclase\/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J Biol Chem 276:44647\u201344652","journal-title":"J Biol Chem"},{"key":"2484_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/BJ20070348","volume":"407","author":"M Russwurm","year":"2007","unstructured":"Russwurm M, Mullershausen F, Friebe A, J\u00e4ger R, Russwurm C, Koesling D (2007) Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators: a systematic approach. Biochem J 407:69\u201377","journal-title":"Biochem J"},{"key":"2484_CR78","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jacc.2019.12.049","volume":"75","author":"AR Sabbatini","year":"2020","unstructured":"Sabbatini AR, Kararigas G (2020) Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC Review Topic of the Week. J Am Coll Cardiol 75:1074\u20131082","journal-title":"J Am Coll Cardiol"},{"key":"2484_CR79","doi-asserted-by":"publisher","unstructured":"Sandner P (2018) From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators. Biol Chem\u00a0399(7):679\u2013690. https:\/\/doi.org\/10.1515\/hsz-2018-0155","DOI":"10.1515\/hsz-2018-0155"},{"key":"2484_CR80","doi-asserted-by":"crossref","unstructured":"Sandner P, Vakalopoulos A, Hahn MG, Stasch JP, Follmann M (2021) Soluble guanylate cyclase stimulators and their potential use: a patent review. Expert Opin Ther Pat\u00a031(3):203\u2013222","DOI":"10.1080\/13543776.2021.1866538"},{"key":"2484_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.864706","volume":"16","author":"D Savitska","year":"2022","unstructured":"Savitska D, Hess M, Calis D, Marchetta P, Harasztosi C, Fink S, Eckert P, Ruth P, Ruttiger L, Knipper M, Singer W (2022) Stress affects central compensation of neural responses to cochlear synaptopathy in a cGMP-dependent way. Front Neurosci 16:864706","journal-title":"Front Neurosci"},{"key":"2484_CR82","doi-asserted-by":"publisher","first-page":"12312","DOI":"10.1073\/pnas.0703944104","volume":"104","author":"N Sayed","year":"2007","unstructured":"Sayed N, Baskaran P, Ma X, van den Akker F, Beuve A (2007) Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 104:12312\u201312317","journal-title":"Proc Natl Acad Sci USA"},{"key":"2484_CR83","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/bph.15514","volume":"179","author":"H Schmidt","year":"2022","unstructured":"Schmidt H, Bottcher A, Gross T, Schmidtko A (2022) cGMP signalling in dorsal root ganglia and the spinal cord: various functions in development and adulthood. Br J Pharmacol 179:2361\u20132377","journal-title":"Br J Pharmacol"},{"key":"2484_CR84","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tibs.2021.12.008","volume":"47","author":"R Seifert","year":"2022","unstructured":"Seifert R, Schirmer B (2022) cCMP and cUMP come into the spotlight, finally. Trends Biochem Sci 47:461\u2013463","journal-title":"Trends Biochem Sci"},{"key":"2484_CR85","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1126\/science.1133427","volume":"314","author":"T Sjoblom","year":"2006","unstructured":"Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268\u2013274","journal-title":"Science"},{"key":"2484_CR86","doi-asserted-by":"publisher","unstructured":"Stehle D, Xu MZ, Schomber T, Hahn MG, Schweda F, Feil S, Kraehling JR, Eitner F, Patzak A, Sandner P, Feil R, B\u00e9nardeau A (2021) Novel sGC activators increase glomerular cGMP, induce vasodilation, and improve blood flow in the murine kidney. Br J Pharmacol\u00a0179(11):2476\u20132489. https:\/\/doi.org\/10.1111\/bph.15586","DOI":"10.1111\/bph.15586"},{"key":"2484_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12958-022-00906-5","volume":"20","author":"P Straczynska","year":"2022","unstructured":"Straczynska P, Papis K, Morawiec E, Czerwinski M, Gajewski Z, Olejek A, Bednarska-Czerwinska A (2022) Signaling mechanisms and their regulation during in vivo or in vitro maturation of mammalian oocytes. Reprod Biol Endocrinol 20:37","journal-title":"Reprod Biol Endocrinol"},{"key":"2484_CR88","doi-asserted-by":"publisher","unstructured":"Sumi MP, Ghosh A (2022) Hsp90 in Human Diseases: Molecular Mechanisms to Therapeutic Approaches. Cells\u00a011(6):976. https:\/\/doi.org\/10.3390\/cells11060976","DOI":"10.3390\/cells11060976"},{"key":"2484_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110483","volume":"38","author":"J Szczurkowska","year":"2022","unstructured":"Szczurkowska J, Guo A, Martin J, Lee SI, Martinez E, Chien CT, Khan TA, Singh R, Dadson D, Tran TS, Pautot S, Shelly M (2022) Semaphorin3A\/PlexinA3 association with the Scribble scaffold for cGMP increase is required for apical dendrite development. Cell Rep 38:110483","journal-title":"Cell Rep"},{"key":"2484_CR90","doi-asserted-by":"crossref","unstructured":"Tal N, Morehouse BR, Millman A, Stokar-Avihail A, Avraham C, Fedorenko T, Yirmiya E, Herbst E, Brandis A, Mehlman T, Oppenheimer-Shaanan Y, Keszei AFA, Shao S, Amitai G, Kranzusch PJ, Sorek R (2021) Cyclic CMP and cyclic UMP mediate bacterial immunity against phages. Cell\u00a0184(23):5728\u20135739.e16","DOI":"10.1016\/j.cell.2021.09.031"},{"key":"2484_CR91","doi-asserted-by":"publisher","first-page":"8482","DOI":"10.1038\/ncomms9482","volume":"6","author":"R Thoonen","year":"2015","unstructured":"Thoonen R, Cauwels A, Decaluwe K, Geschka S, Tainsh RE, Delanghe J, Hochepied T, De Cauwer L, Rogge E, Voet S, Sips P, Karas RH, Bloch KD, Vuylsteke M, Stasch JP, Van de Voorde J, Buys ES, Brouckaert P (2015) Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice. Nat Commun 6:8482","journal-title":"Nat Commun"},{"key":"2484_CR92","doi-asserted-by":"publisher","unstructured":"Tolone A, Belhadj S, Rentsch A, Schwede F, Paquet-Durand F (2019) The cGMP pathway and inherited photoreceptor degeneration: targets, compounds, and biomarkers.\u00a0Genes (Basel) 10(6):453. https:\/\/doi.org\/10.3390\/genes10060453","DOI":"10.3390\/genes10060453"},{"key":"2484_CR93","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1001\/jama.2020.16641","volume":"324","author":"JE Udelson","year":"2020","unstructured":"Udelson JE, Lewis GD, Shah SJ, Zile MR, Redfield MM, Burnett J Jr, Parker J, Seferovic JP, Wilson P, Mittleman RS, Profy AT, Konstam MA (2020) Effect of praliciguat on peak rate of oxygen consumption in patients with heart failure with preserved ejection fraction: the CAPACITY HFpEF randomized clinical trial. JAMA 324:1522\u20131531","journal-title":"JAMA"},{"key":"2484_CR94","doi-asserted-by":"publisher","first-page":"ar8","DOI":"10.1091\/mbc.E21-04-0171","volume":"32","author":"PJM van Haastert","year":"2021","unstructured":"van Haastert PJM, Keizer-Gunnink I, Pots H, Ortiz-Mateos C, Veltman D, van Egmond W, Kortholt A (2021) Forty-five years of cGMP research in Dictyostelium: understanding the regulation and function of the cGMP pathway for cell movement and chemotaxis. Mol Biol Cell 32:ar8","journal-title":"Mol Biol Cell"},{"key":"2484_CR95","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1111\/bph.15849","volume":"179","author":"A Velagic","year":"2022","unstructured":"Velagic A, Li JC, Qin CX, Li M, Deo M, Marshall SA, Anderson D, Woodman OL, Horowitz JD, Kemp-Harper BK, Ritchie RH (2022) Cardioprotective actions of nitroxyl donor Angeli\u2019s salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance. Br J Pharmacol 179:4117\u20134135","journal-title":"Br J Pharmacol"},{"key":"2484_CR96","doi-asserted-by":"publisher","unstructured":"Wagner BM, Robinson JW, Lin YW, Lee YC, Kaci N, Legeai-Mallet L, Potter LR (2021a) Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism. JCI insight\u00a06(9):e147832. https:\/\/doi.org\/10.1172\/jci.insight.147832","DOI":"10.1172\/jci.insight.147832"},{"key":"2484_CR97","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1089\/hum.2021.121","volume":"32","author":"JE Wagner","year":"2021","unstructured":"Wagner JE, Zobel L, Gerhardt MJ, O\u2019Riordan CR, Frederick A, Petersen-Jones SM, Biel M, Michalakis S (2021b) In vivo potency testing of subretinal rAAV5.hCNGB1 gene therapy in the Cngb1 knockout mouse model of retinitis pigmentosa. Hum Gene Ther 32:1158\u20131170","journal-title":"Hum Gene Ther"},{"key":"2484_CR98","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100600RRR","volume":"36","author":"BM Wagner","year":"2022","unstructured":"Wagner BM, Robinson JW, Healy CL, Gauthier M, Dickey DM, Yee SP, Osborn JW, O\u2019Connell TD, Potter LR (2022) Guanylyl cyclase-A phosphorylation decreases cardiac hypertrophy and improves systolic function in male, but not female, mice. FASEB J 36:e22069","journal-title":"FASEB J"},{"key":"2484_CR99","doi-asserted-by":"publisher","unstructured":"Wittenborn EC, Marletta MA (2021) Structural perspectives on the mechanism of soluble guanylate cyclase activation. Int J Mol Sci\u00a022(11):5439. https:\/\/doi.org\/10.3390\/ijms22115439","DOI":"10.3390\/ijms22115439"},{"key":"2484_CR100","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.niox.2018.03.019","volume":"76","author":"J Wobst","year":"2018","unstructured":"Wobst J, Schunkert H, Kessler T (2018) Genetic alterations in the NO-cGMP pathway and cardiovascular risk. Nitric Oxide Biol Chem 76:105\u2013112","journal-title":"Nitric Oxide Biol Chem"},{"key":"2484_CR101","doi-asserted-by":"publisher","first-page":"1007768","DOI":"10.3389\/fmolb.2022.1007768","volume":"9","author":"G Wu","year":"2022","unstructured":"Wu G, Sharina I, Martin E (2022) Soluble guanylyl cyclase: molecular basis for ligand selectivity and action in vitro and in vivo. Front Mol Biosci 9:1007768","journal-title":"Front Mol Biosci"},{"key":"2484_CR102","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.7150\/ijbs.60354","volume":"17","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Yang D, Xiang J, Zhou J, Cao H, Che Q, Bai Y, Guo J, Su Z (2021) Non-shivering thermogenesis signalling regulation and potential therapeutic applications of brown adipose tissue. Int J Biol Sci 17:2853\u20132870","journal-title":"Int J Biol Sci"},{"key":"2484_CR103","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41594-021-00699-y","volume":"29","author":"X Zheng","year":"2022","unstructured":"Zheng X, Hu Z, Li H, Yang J (2022a) Structure of the human cone photoreceptor cyclic nucleotide-gated channel. Nat Struct Mol Biol 29:40\u201346","journal-title":"Nat Struct Mol Biol"},{"key":"2484_CR104","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s42003-022-03120-6","volume":"5","author":"X Zheng","year":"2022","unstructured":"Zheng X, Li H, Hu Z, Su D, Yang J (2022b) Structural and functional characterization of an achromatopsia-associated mutation in a phototransduction channel. Commun Biol 5:190","journal-title":"Commun Biol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02484-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02484-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02484-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T09:04:27Z","timestamp":1689152667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02484-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":104,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2484"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02484-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"10 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Review article\/non-applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"AF, MR, and AS declare that they have no competing interests. PS and JRK are full-time employees of Bayer AG, Pharmaceuticals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}